Recital 2, Regulation (EU) 2017/1511

In forcesince 30 Aug 2017

The approval periods of the active substances beta-cyfluthrin, deltamethrin, dimethenamid-p, flufenacet, flurtamone, fosthiazate, iprodione and silthiofam were last extended by Commission Implementing Regulation (EU) 2016/950 [Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (OJ L 159, 16.6.2016, p. 3).]. The approval periods of those substances will expire on 31 October 2017.